Transposagen Biopharmaceuticals' Seed - II Round

Transposagen Biopharmaceuticals raised a round of funding on July 18, 2012.

Transposagen Biopharmaceuticals produces genetically modified MutaRat Knockout Animal Models of human diseases for drug discovery and development. Per the company, the production of animal models is …

Articles about Transposagen Biopharmaceuticals' Seed - II Round: